查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1626519

输液帮浦市场：按应用、最终用户、地区、范围和预测，2024 年至 2031 年

Infusion Pump Market By Application (Chemotherapy/Oncology, Diabetes, Gastroenterology), By End-User (Hospitals, Home Care Settings, Ambulatory Care Settings), By Geographic Scope And Forecast & Region for 2024-2031
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

输液帮浦市场评估，2024 年至 2031 年

由于对能够精确且可控地向患者输液、输送药物和营养的创新医疗设备的需求不断增加，输液帮浦市场正在蓬勃发展。这些帮浦在医院和家庭护理环境中必不可少，特别是对于需要持续输液治疗（例如疼痛管理、化疗和胰岛素治疗）的患者。因此，输液帮浦的需求预计将飙升，到 2024 年市场规模将超过 151.2 亿美元，到 2031 年将达到 240.9 亿美元的估值。

提高安全性和连接性的智慧帮浦等技术改进有助于提高接受度。由于慢性病的流行和老年人口的不断增长进一步推动了对输液泵的需求，预计市场将继续增长。因此，由于远端连接越来越受欢迎，市场将从 2024 年到 2031 年以 6.00% 的复合年增长率成长。

输液帮浦市场定义/概述

输液帮浦是一种以可控方式将药物、营养物质或血液等液体输送到患者体内的医疗设备。这些帮浦广泛应用于医院、诊所和家庭护理环境，对于化疗、疼痛管理和静脉营养等治疗至关重要，因为它们可以确保在规定的时间内精确的液体输送率。

输液帮浦广泛用于给患者註射补充剂和药物，如胰岛素、荷尔蒙、抗生素、化疗药物和止痛药。这些设备比手动输液有几个优点，包括能够以精确编程的速率和自动间隔输注极少量的液体。印度和中国等新兴市场以及专用帮浦的日益普及，为输液帮浦市场参与者带来了巨大的成长机会。

慢性病的增加将如何推动输液帮浦市场的成长？

老年族群中慢性病的发生率不断上升，对输液帮浦的需求也随之增加。随着年龄的增长，人们更容易患上糖尿病、心血管疾病和癌症等疾病，并且往往需要长期药物治疗。输液帮浦提供了一种有效且精确的方法来输送这些药物，从而可以更好地管理慢性疾病。这对于治疗方案复杂或需要多种药物的老年患者尤其重要，因为输液帮浦可以编程为在特定时间间隔输送精确的剂量。

此外，向家庭医疗保健的转变以及改善老年人生活品质的愿望正在推动对便携式和易于使用的输液泵的需求。许多老年人更愿意在自己舒适的家中接受治疗，而不是去医院。输液帮浦技术的进步使得这些设备更加紧凑、更容易使用且适合家庭护理。这一趋势不仅提高了患者的舒适度和独立性，而且还有助于降低长期住院相关的医疗费用，使得输液泵成为老年人护理中越来越重要的一部分。

竞争性定价在医疗机构采用输液帮浦方面将扮演什么角色？

预算限制和成本效益考量严重影响医疗设备（包括输液帮浦）的购买决策。医疗保健提供者面临着在保持高品质护理的同时控製成本的压力，其中输液帮浦的价格范围是一个关键因素。价格具有竞争力且性能可靠、具备基本功能的泵浦更有可能被采用，尤其是在较小的医疗机构和资源受限的环境中。这样的定价策略使得医疗机构无需增加预算就能获得所需的设备，从而释放资源用于其他重要的病患照护领域。

此外，拥有和维护输液帮浦的长期成本也会影响采用率。医疗机构不仅考虑初始购买价格，还考虑维护、维修和消耗品等持续成本。提供具有价格竞争力的泵浦的製造商通常会提供具有成本效益的服务计划、替换零件和相容的消耗品。这种综合定价方法可以促进长期预算规划并可能降低总拥有成本，从而使某些输液泵型号对医疗机构更具吸引力。因此，解决初始成本和长期成本的竞争性定价策略可以显着推动输液帮浦在各种医疗保健环境中的采用。

目录

第 1 章：全球输液帮浦市场：简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章：经过验证的市场研究方法

  • 资料探勘
  • 二次研究
  • 初步研究
  • 专家建议
  • 品质检查
  • 最终审核
  • 数据三角测量
  • 由下而上的方法
  • 自上而下的方法
  • 调查流程
  • 资料来源

第 3 章执行摘要

  • 概述
  • 绝对的获利机会
  • 市场吸引力
  • 未来市场机会

第 4 章 输液帮浦全球市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析

第 5 章 全球输液帮浦市场（依应用）

  • 概述
  • 化疗/肿瘤学
  • 糖尿病
  • 消化道
  • 镇痛/疼痛管理
  • 儿科/新生儿科
  • 血液学
  • 其他

6. 全球输液帮浦市场（依最终用户划分）

  • 概述
  • 医院
  • 家庭医疗保健
  • 门诊护理
  • 学术和研究机构

第 7 章 全球输液帮浦市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
    亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他洛杉矶
  • 中东和非洲
    • 阿拉伯联合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第 8 章全球输液帮浦市场：竞争格局

  • 概述
  • 各公司的市场排名
  • 主要发展策略
  • 公司的地理分布
  • 公司产业足迹
  • ACE 矩阵

第九章 公司简介

  • Becton, Dickinson and Company
  • Roche Diagnostics
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi
  • ICU Medical
  • Medtronic
  • Moog Inc.
  • Smiths Medical
  • Terumo Corporation
  • Roche Diagnostics

第 10 章附录

  • 相关研究
  • 重大进展
简介目录
Product Code: 26268

Infusion Pump Market Valuation - 2024-2031

The infusion pump market is expanding rapidly due to increased demand for innovative medical equipment that enables precise and controlled delivery of fluids, drugs, and nutrition to patients. These pumps are vital in hospitals and home care settings, particularly for patients who need continuous infusion treatments such as pain management, chemotherapy, and insulin therapy. Thus, the growing demand for infusion pumps surged the growth of market size surpassing USD 15.12 Billion in 2024 to reach a valuation of USD 24.09 Billion by 2031.

Technological improvements, such as smart pumps with improved safety and connection, are boosting their acceptance. The increasing prevalence of chronic diseases, combined with the growing older population, is further fueling the demand for infusion pumps, positioning the market for continued growth. Thus, the growing popularity of remote connectivity enables the market to grow at a CAGR of 6.00% from 2024 to 2031.

Infusion Pump Market: Definition/ Overview

An infusion pump is a medical device that supplies fluids, such as drugs, nutrients, or blood, to a patient's body in a controlled manner. These pumps are widely utilized in hospitals, clinics, and home care settings, where they ensure accurate delivery rates over a predetermined period, making them critical for treatments such as chemotherapy, pain management, and intravenous feeding.

Infusion pumps are widely used to administer supplements or medications to patients, such as insulin, hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer several advantages over manual fluid administration, including the ability to deliver fluids in very small volumes at precisely programmed rates or at automated intervals. Emerging markets, such as India and China, present significant growth opportunities for players in the infusion pump market, alongside the increasing adoption of specialty pumps.

How Does the Increasing Prevalence of Chronic Diseases Surge the Growth of Infusion Pump Market?

The increased prevalence of chronic diseases among the elderly drives the need for infusion pumps. As people age, they become more susceptible to conditions such as diabetes, cardiovascular diseases, and cancer, which often require long-term medication administration. Infusion pumps provide an efficient and accurate method for delivering these medications, allowing for better management of chronic conditions. This is particularly crucial for elderly patients who may have complex treatment regimens or require multiple medications, as infusion pumps can be programmed to deliver precise dosages at specific intervals.

Furthermore, the shift towards home healthcare and the desire for improved quality of life among the elderly population boosts the demand for portable and user-friendly infusion pumps. Many older adults prefer to receive treatment in the comfort of their homes rather than in hospital settings. Advances in infusion pump technology have made these devices more compact, easier to use, and suitable for home care. This trend not only improves patient comfort and independence but also helps reduce healthcare costs associated with prolonged hospital stays, making infusion pumps an increasingly essential component of elderly care.

What Role Does Competitive Pricing Play in Influencing the Adoption of Infusion Pumps Among Healthcare Facilities?

Budget constraints and cost-effectiveness considerations significantly impact healthcare facilities' purchasing decisions for medical equipment, including infusion pumps. As healthcare providers face increasing pressure to manage costs while maintaining high-quality care, the price point of infusion pumps becomes a critical factor. Competitively priced pumps that offer reliable performance and essential features are more likely to be adopted, especially by smaller healthcare facilities or those in resource-constrained settings. This pricing strategy allows facilities to acquire necessary equipment without overstretching their budgets, enabling them to allocate resources to other critical areas of patient care.

Furthermore, the long-term cost implications associated with infusion pump ownership and maintenance also influence adoption rates. Healthcare facilities consider not only the initial purchase price but also ongoing expenses such as maintenance, repairs, and consumables. Manufacturers offering competitively priced pumps often provide cost-effective service plans, replacement parts, and compatible disposables. This comprehensive approach to pricing can make certain infusion pump models more attractive to healthcare facilities, as it allows for better long-term budget planning and potentially lower total cost of ownership. Consequently, competitive pricing strategies that address both upfront and long-term costs can significantly drive the adoption of infusion pumps across various healthcare settings.

Category-Wise Acumens

How does the Increasing Demand for Chemotherapy/Oncology Treatments Influence the Adoption of Infusion Pumps in Hospitals?

The chemotherapy/oncology segment dominates in the infusion pump market owing to the precision and safety requirements in chemotherapy administration drive the need for advanced infusion pumps. Chemotherapy drugs often require exact dosing and controlled delivery rates to maximize effectiveness while minimizing side effects. Modern infusion pumps offer programmable features that allow for precise control over drug delivery, including multi-step infusions and time-specific dosing schedules. This level of accuracy is crucial in oncology treatments, where even small variations in drug administration can impact treatment efficacy and patient safety. Consequently, hospitals are increasingly adopting smart infusion pumps with built-in safety features and drug libraries specific to oncology protocols.

The rise in outpatient and ambulatory cancer care services fuels the demand for portable and versatile infusion pumps. As more cancer treatments shift from inpatient to outpatient settings, hospitals require infusion pumps that can seamlessly transition between different care environments. Portable pumps allow patients to receive continuous treatment while maintaining mobility, improving their quality of life during lengthy chemotherapy regimens. This trend has led to increased adoption of lightweight, battery-operated infusion pumps that can be easily programmed for home use or monitored remotely by healthcare providers, enhancing the flexibility of cancer care delivery in hospital-affiliated outpatient clinics and home settings.

How does the Complex Drug Protocol and Need for Intricate Treatment Foster the Growth of Hospital Segment?

The hospital segment dominates the infusion pump market driven by the complexity of drug protocols and dosing regimens in hematology poses a major challenge. Hematological conditions often require intricate treatment plans involving multiple medications, precise dosing schedules, and frequent adjustments based on patient response. Integrating infusion pumps to accurately deliver these complex regimens demands sophisticated programming capabilities and seamless integration with electronic health records (EHR) systems. Hospitals must ensure that their infusion pumps can handle multi-step infusions, drug sequencing, and rapid protocol changes, which often necessitates investment in advanced smart pumps and extensive staff training to minimize errors and optimize treatment efficacy.

Furthermore, Compatibility issues with blood products and specialized hematology medications create another significant hurdle. Many hematology treatments involve the infusion of blood products, clotting factors, or highly viscous medications that may not be compatible with standard infusion pump settings. Hospitals must carefully select pumps that can handle these specialized products without compromising their integrity or causing equipment malfunction. Additionally, the risk of medication errors is heightened due to the critical nature of many hematology treatments. This requires hospitals to implement robust safety features, including barcode scanning, drug libraries specific to hematology, and alert systems to prevent potentially life-threatening mistakes during infusion therapy.

Country/Region-wise Acumens

What Impact do Regulatory Standards in North America have on the Development and Adoption of Infusion Pump Technologies?

North America substantially dominates the infusion pump market owing to the stringent safety and performance requirements set by regulatory bodies like the U.S. Food and Drug Administration (FDA) drive innovation in infusion pump design. These regulations mandate rigorous testing and validation processes to ensure pump reliability, accuracy, and safety. Manufacturers must demonstrate compliance with standards such as IEC 60601-1 for electrical safety and IEC 60601-2-24 for infusion pump performance. This regulatory environment pushes companies to invest heavily in research and development, resulting in advanced features like integrated drug libraries, dose error reduction systems, and interoperability capabilities. While these requirements can extend development timelines and increase costs, they ultimately lead to safer, more effective infusion pump technologies that healthcare providers can trust.

Furthermore, Regulatory oversight also influences the adoption rate of new infusion pump technologies in healthcare settings. The FDA's premarket approval (PMA) process for Class III medical devices, which includes many advanced infusion pumps, involves extensive clinical trials and data submission. This rigorous approval pathway can slow the introduction of novel technologies to the market. However, it also instills confidence among healthcare providers and patients, facilitating faster adoption once approval is granted. Additionally, regulatory bodies' post-market surveillance requirements, such as the FDA's adverse event reporting system, encourage ongoing improvements and updates to existing pump technologies. This continuous feedback loop between regulators, manufacturers, and end-users fosters a culture of constant innovation and refinement in the infusion pump industry.

How does the Healthcare Infrastructure in the Middle East & Africa Affect the Availability and Utilization of Infusion Pumps?

Asia Pacific is anticipated to witness the fastest growth in the infusion pump market driven by the disparities in healthcare development across the region creating a varied landscape for infusion pump adoption. In economically advanced areas, such as the Gulf Cooperation Council (GCC) countries, state-of-the-art medical facilities are equipped with modern infusion technologies, driving high utilization rates. These nations often have well-funded healthcare systems that can afford and maintain advanced infusion pumps. However, in less developed parts of Africa and conflict-affected areas of the Middle East, healthcare infrastructure is often underdeveloped or damaged. This leads to limited availability of infusion pumps, with many facilities relying on older, less sophisticated models or manual infusion methods. The stark contrast in resources affects not only the distribution of infusion pumps but also the types of pumps available in different areas.

Challenges in maintenance, training, and supply chain logistics significantly influence the utilization of infusion pumps. Many parts of the Middle East & Africa face difficulties in ensuring consistent power supply and maintaining sterile conditions, which are crucial for the proper functioning of infusion pumps. Additionally, there's often a shortage of trained healthcare professionals who can operate and maintain these devices effectively. Supply chain issues, including difficulties in importing replacement parts and consumables, can lead to prolonged periods of pump inactivity. These factors result in underutilization of available infusion pumps and reluctance among some healthcare providers to invest in more advanced models, despite their potential benefits. Consequently, efforts to improve infusion pump utilization in the region often focus not just on increasing availability, but also on enhancing infrastructure, training, and supply chain resilience.

Competitive Landscape

The Infusion Pump Market is highly competitive, characterized by rapid technological advancements, increasing demand for precision in drug delivery, and a focus on enhancing patient safety and regulatory compliance across healthcare settings.

Some of the prominent players operating in the infusion pump market include:

Becton

Dickinson, and Company

Braun Melsungen

Baxter International

Fresenius Kabi

ICU Medical

Medtronic

Moog Inc.

Smiths Medical

Terumo Corporation

Roche Diagnostics

Infusion Pump Market Latest Developments

In March 2024, Medtronic announced the launch of an AI-powered smart infusion system Medtronic introduced a new infusion pump with integrated artificial intelligence capabilities. The system uses machine learning algorithms to predict potential infusion errors and optimize drug delivery rates, significantly enhancing patient safety and treatment efficacy.

In January 2024, B. Braun expanded its infusion pump portfolio with the acquisition of B. Braun Melsungen AG a startup specializing in miniature infusion pump technology. This strategic move allows B. Braun to enter the wearable infusion pump market, targeting ambulatory care and home healthcare segments.

In November 2023, Baxter International announced the launch of a cybersecurity-enhanced pump Baxter a new line of infusion pumps with advanced cybersecurity features.

Infusion Pump Market, By Category

  • Application:
  • Chemotherapy/Oncology
  • Diabetes
  • Gastroenterology
  • End-User:
  • Hospitals
  • Home Care Settings
  • Ambulatory Care Settings
  • Academic & Research Institutes
  • Geography:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INFUSION PUMP MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data mining
  • 2.2 Secondary research
  • 2.3 Primary research
  • 2.4 Subject matter expert advice
  • 2.5 Quality check
  • 2.6 Final review
  • 2.7 Data Triangulation
  • 2.8 Bottom-up approach
  • 2.9 Top-down approach
  • 2.10 Research flow
  • 2.11 Data sources

3 EXECUTIVE SUMMARY

  • 3.1 Overview
  • 3.2 Absolute $ Opportunity
  • 3.3 Market attractiveness
  • 3.4 Future Market Opportunities

4 GLOBAL INFUSION PUMP MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL INFUSION PUMP MARKET, BY APPLICATION

  • 5.1 Overview
  • 5.2 Chemotherapy/Oncology
  • 5.3 Diabetes
  • 5.4 Gastroenterology
  • 5.5 Analgesia/Pain Management
  • 5.6 Pediatrics/Neonatology
  • 5.7 Hematology
  • 5.8 Other

6 GLOBAL INFUSION PUMP MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Home Care Settings
  • 6.4 Ambulatory Care Settings
  • 6.5 Academic & Research Institutes

7 GLOBAL INFUSION PUMP MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of LA
  • 7.6 Middle East & Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

8 GLOBAL INFUSION PUMP MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Becton, Dickinson and Company
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Business Breakdown
    • 9.1.4 Product Benchmarking
    • 9.1.5 Key Developments
    • 9.1.6 Winning Imperatives
    • 9.1.7 Current Focus & Strategies
    • 9.1.8 Threat from Competition
    • 9.1.9 SWOT Analysis
  • 9.2 Roche Diagnostics
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Business Breakdown
    • 9.2.4 Product Benchmarking
    • 9.2.5 Key Developments
    • 9.2.6 Winning Imperatives
    • 9.2.7 Current Focus & Strategies
    • 9.2.8 Threat from Competition
    • 9.2.9 SWOT Analysis
  • 9.3 B. Braun Melsungen
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Business Breakdown
    • 9.3.4 Product Benchmarking
    • 9.3.5 Key Developments
    • 9.3.6 Winning Imperatives
    • 9.3.7 Current Focus & Strategies
    • 9.3.8 Threat from Competition
    • 9.3.9 SWOT Analysis
  • 9.4 Baxter International
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Business Breakdown
    • 9.4.4 Product Benchmarking
    • 9.4.5 Key Developments
    • 9.4.6 Winning Imperatives
    • 9.4.7 Current Focus & Strategies
    • 9.4.8 Threat from Competition
    • 9.4.9 SWOT Analysis
  • 9.5 Fresenius Kabi
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Business Breakdown
    • 9.5.4 Product Benchmarking
    • 9.5.5 Key Developments
    • 9.5.6 Winning Imperatives
    • 9.5.7 Current Focus & Strategies
    • 9.5.8 Threat from Competition
    • 9.5.9 SWOT Analysis
  • 9.6 ICU Medical
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Business Breakdown
    • 9.6.4 Product Benchmarking
    • 9.6.5 Key Developments
    • 9.6.6 Winning Imperatives
    • 9.6.7 Current Focus & Strategies
    • 9.6.8 Threat from Competition
    • 9.6.9 SWOT Analysis
  • 9.7 Medtronic
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Business Breakdown
    • 9.7.4 Product Benchmarking
    • 9.7.5 Key Developments
    • 9.7.6 Winning Imperatives
    • 9.7.7 Current Focus & Strategies
    • 9.7.8 Threat from Competition
    • 9.7.9 SWOT Analysis
  • 9.8 Moog Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Business Breakdown
    • 9.8.4 Product Benchmarking
    • 9.8.5 Key Developments
    • 9.8.6 Winning Imperatives
    • 9.8.7 Current Focus & Strategies
    • 9.8.8 Threat from Competition
    • 9.8.9 SWOT Analysis
  • 9.9 Smiths Medical
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Business Breakdown
    • 9.9.4 Product Benchmarking
    • 9.9.5 Key Developments
    • 9.9.6 Winning Imperatives
    • 9.9.7 Current Focus & Strategies
    • 9.9.8 Threat from Competition
    • 9.9.9 SWOT Analysis
  • 9.10 Terumo Corporation
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Business Breakdown
    • 9.10.4 Product Benchmarking
    • 9.10.5 Key Developments
    • 9.10.6 Winning Imperatives
    • 9.10.7 Current Focus & Strategies
    • 9.10.8 Threat from Competition
    • 9.10.9 SWOT Analysis
  • 9.11 Roche Diagnostics
    • 9.11.1 Company Overview
    • 9.11.2 Company Insights
    • 9.11.3 Business Breakdown
    • 9.11.4 Product Benchmarking
    • 9.11.5 Key Developments
    • 9.11.6 Winning Imperatives
    • 9.11.7 Current Focus & Strategies
    • 9.11.8 Threat from Competition
    • 9.11.9 SWOT Analysis

10 Appendix

  • 10.1 Related Research
  • 10.2 Key Developments